See More StocksHome

IBRX

Immunitybio Inc

Show Trading View Graph

Mentions (24Hr)

2

0.00% Today

Reddit Posts

r/wallstreetbetsSee Post

I will give you a stock

r/pennystocksSee Post

IBRX - I don't understand something

r/WallStreetbetsELITESee Post

Biotechs on the Radar Screen: $IOVA, $IBRX, $SILO, $LUMO, $SMMT

r/StockMarketSee Post

Biotechs on the Radar Screen: $IOVA, $IBRX, $SILO, $LUMO, $SMMT

r/pennystocksSee Post

Biotechs on the Radar Screen: $IOVA, $IBRX, $SILO, $LUMO, $SMMT

r/WallStreetbetsELITESee Post

Biotechs on the Radar Screen: $IBRX, $ILO, $LUMO, $SMMT

r/WallStreetbetsELITESee Post

Biotechs on the Radar Screen: $IBRX, $ILO, $LUMO, $SMMT

r/StockMarketSee Post

Biotechs on the Radar Screen: $IBRX, $ILO, $LUMO, $SMMT

r/pennystocksSee Post

Biotechs on the Radar Screen: $IBRX, $ILO, $LUMO, $SMMT

r/pennystocksSee Post

🚨PENNY STOCKS & SMALL CAPS' CATALYSTS - Sept 12!

r/wallstreetbetsSee Post

Dealing with Fears of Loss, that leads to many lost opportunities - help needed

r/optionsSee Post

Dealing with Fears of Loss, that leads to many lost opportunities - help needed

r/pennystocksSee Post

June's penny stock marvels: supercharge your portfolio with these gems!

r/ShortsqueezeSee Post

Will $IBRX go to $7 or even $10 by may 23?

r/ShortsqueezeSee Post

IBRX is ready for a squeeze, has just begun.

r/WallStreetbetsELITESee Post

$IBRX in strong uptrend.

r/ShortsqueezeSee Post

IBRX get in now before it squeezes!!

r/StockMarketSee Post

A List of Biotech Stocks With Major Price Movement and Continued Upside Potential.

r/wallstreetbetsSee Post

$IBRX Strong after hours buying and chart grabbed my attention..$2 break could really send this..news of late points to some big things com.

r/pennystocksSee Post

Penny stocks in focus ($TRKA, $BTBT, $IBRX)

r/ShortsqueezeSee Post

ImmunityBio (IBRX) Set To Bounce

r/wallstreetbetsSee Post

IBRX on the launch pad to double digit area

r/wallstreetbetsSee Post

Top Doctors Discuss Blow Out Phase 3 results of Immunity Bio Quilt Study to treat bladder cancer

r/wallstreetbetsSee Post

Double YOLO - IBRX and SKLZ

r/wallstreetbetsSee Post

IBRX ImmunityBio has the vaccine for all covid variants and more

r/wallstreetbetsSee Post

IBRX ImmunityBio has the cure for all covid variants

r/wallstreetbetsSee Post

IBRX expecting BLA submission to FDA this month

r/wallstreetbetsSee Post

IBRX on the verge of skyrocketing

r/wallstreetbetsSee Post

$IBRX I am an idiot. I’m all in and I’m getting a biblical ass pounding. Every fucking stock I buy, it dies. #mayor of tard-city

r/wallstreetbetsSee Post

$IBRX. I am an idiot. Tell me why I am being a tard and blowing away my paycheck on this pile of dogeshit.

r/ShortsqueezeSee Post

$IBRX , $AMRS. Complete Joint Venture. NFA.

r/ShortsqueezeSee Post

$IBRX , Nfa. News. Complete Joint Venture

r/wallstreetbetsSee Post

A Keytruda competitor has a BLA filing and the market is overlooking them!

r/wallstreetbetsSee Post

Immunitybio is the next big thing or will they fade away due to the greed of the fat suits?

r/wallstreetbetsSee Post

TKO Covid-19

r/wallstreetbetsSee Post

TKO Covid-19

r/wallstreetbetsSee Post

TKO Covid-19 Once and For All

r/wallstreetbetsSee Post

Apes 🦍 needed to End Covid - Buy IBRX - 1st 2nd Gen Vaccine

r/wallstreetbetsSee Post

IBRX ImmunityBio announces primary endpoint met in bladder cancer trial

r/wallstreetbetsSee Post

IBRX ImmunityBio

r/wallstreetbetsSee Post

IBRX stock is one to get in on

r/wallstreetbetsSee Post

https://www.streetinsider.com/Corporate+News/ImmunityBio+%28IBRX%29+Announces+Positive+Durable+Responses+in+BCG+Unresponsive+Bladder+Cancer+Patients+with+a+Complete+Response+Rate+of+72%25%2C+Median+Duration+of+Complete+Response+of+19.9+Months%2C+and+85%25+R/18931016.html

r/wallstreetbetsSee Post

ImmunityBio (IBRX) Announces Positive Durable Responses in BCG Unresponsive Bladder Cancer Patients with a Complete Response Rate of 72%, Median Duration of Complete Response of 19.9 Months, and 85% R

r/wallstreetbetsSee Post

$IBRX their bladder cancer treatment is nearly 2x more effective than the leading treatment.

r/wallstreetbetsSee Post

IBRX, Immunitybio, 72% Complete Response for bladder cancer

r/wallstreetbetsSee Post

IBRX, Immunitybio, 72% Complete Response for bladder cancer

r/stocksSee Post

IBRX, Immunitybio, 72% Complete Response for bladder cancer

Mentions

Idk man I heard IBRX being talked up in a similar tone and it pumped and dumped

Mentions:#IBRX

Is IBRX capable of anything other than shitting the bed?

Mentions:#IBRX

Thinking about buying back my IBRX covered calls

Mentions:#IBRX

IBRX...... curing cancer without chemo. About to start it's rise to the moon. Starts before Q2 reporting then will climb without looking back.

Mentions:#IBRX

I like your mindset about URGN and IBRX. But if you're going to be a consistent winner, you're going to have to get off this idea that a high CTB and zero shares available to short is a GOOD thing. Maybe on mid to large cap stocks (GME, CVNA, RILY etc.). But on penny stocks, microcaps and SPACs, it's a clear sign the stock will tank. Shorters are that desperate to short because they KNOW something that you don't. Not THINK, but KNOW, with 100% certainty. Because they are the ones with the access to these garbage financing deals, taking the arbitrage through financial engineering, and the high CTB is just the cost of doing business.

0 shares available to borrow for AEMD and CTB through the roof. Im a novice but I smell a squeeze waiting to happen. URGN looks great as well. I will definitely get some shares. Would love to play options on URGN but high premiums for ATM. Reminds me of IBRX. Great company as well that has good stuff going on. Just a matter of when it’ll pop again.

I'll answer your question with a question of my own. How big is GME's market cap? CVNA? RILY? SMCI? IBRX? All of these had short squeezes and/or are popular with the short squeeze crowd. You have it the opposite. Smaller market cap companies are WORSE to squeeze. Because they usually end up being garbage dilution machines and fuck over retail suckers who buy their crap stock. See: BURU for a recent example.

I’m not sure what is looked at for short squeezes but does IBRX have a good chance?

Mentions:#IBRX

I vomited in my mouth just reading that fluff headline. Companies with $3 million market cap and barely any cash don't do transformative anything in biotech. You need a minimum of $50 million but more like $500 million or more to make something work in oncology. Look how much money IBRX spent just to get to where they are.

Mentions:#IBRX

Right there with you. I’ve got 20 $10 calls expiring in January and creeping up to 2k shares at $6 average. I’m in this to the end. Years ago, like 15 or so, I was seriously into Genentech. Everything I read about them was solid and I had that gut feeling. But I was also freshly married and poor. Sure as shit it took off and eventually was bought out by Roche. I’ve hated myself for it ever since. Luckily I think this is my redemption stock. I’m very confident in IBRX.

Mentions:#IBRX

I'm heavy in IBRX, cost basis around $7 and a bunch of $7.50 calls expiring 1/17/25

Mentions:#IBRX

Further proof you are either a swing trader, scalp trading, or thrive on shorting stocks. You’ve “pushed” $SLS, $IBRX, and definitely $GDHG many times…and conveniently your timing of these “DD” posts coincide with a price spike and then a major drop usually lower than the price spike the previous day.

Can cat man mention IBRX? There’s decent short squeeze potential and more importantly I can sell my bags.

Mentions:#IBRX

IBRX bag holders where you at??? I was promised 20 dollars by end of year why the fuck did the company authorize the issuance of 20 million more additional shares if not to dilute?? And why are they hiding sales data and have said nothing about it in the investor conference.

Mentions:#IBRX

IBRX has been a loser since I picked up shares. Should I dump?

Mentions:#IBRX

I know it's an old thread but would appreciate your opinion on the current state of IBRX. I hold plenty of shares and needles to say I am in deep red. Do you think it still holds promise and can be a long term winner?!?

Mentions:#IBRX

Anyone know wtf happened to IBRX today? What did they say? It tanked right after the investor presentation and I can’t find any news as to why

Mentions:#IBRX

aye partna take a look at IBRX

Mentions:#IBRX

IBRX looking good this morning

Mentions:#IBRX

IBRX is the only one that really checks all of those boxes. SPWR has some aspects of that too. But people needs to learn to differentiate between stocks with short squeeze potential and stocks with high short interest. A stock with high short interest but is diluting like crazy and shorts are riding 90% profits cannot be squeezed. You might get a small bounce on short covering (aka they are taking their profits) but you can't squeeze them. In contrast, a stock like LPA which may have had 50,000 short interest, if that...but those few shorts got skull fucked. On a stock that barely has any volume, that's enough to cause a squeeze.

Okay? And it'll also have 400 million shares outstanding and a pretty mid short interest compared to any number of stocks. IBRX is better. CVNA, a company I don't like at all, is better. At least CVNA has had a real short squeeze - a sustained and brutal increase in the SP followed by actual short covering.

Mentions:#IBRX#CVNA

It's not at all that. Why? Because it already pumped and dumped twice in the last month. By that very nature, it's disqualified to be the most tightly wound up spring loaded cannon. That honor almost certainly goes to some stock you never heard of. Like LPA two weeks ago. In terms of short squeeze potential of more well known names, GME isn't the top dog there either. That belongs to IBRX. Just facts. IBRX has a far higher % short interest.

Mentions:#LPA#GME#IBRX

I agree with IBRX. That will have a good day tomorrow and next earnings in August

Mentions:#IBRX

Loading up more IBRX

Mentions:#IBRX

Update on my previous post in this thread. IBRX jumping a bit in PM.

Mentions:#IBRX

Just copying what I wrote in yesterday's weekend thread for those who are too cool to visit the weekend thread but may still be interested in a lotto ticket: "Good morning degens. Usually I just make shitty jokes at other people's expense but this time I'm actually posting some potentially relevant info. IBRX has popped up a few times on here, either someone else posting DD or me spamming the ticker like the most basic bagholder ever (not really but it sure feels like it). Anyway, they have an AGM scheduled on Tuesday with some speculation of positive news following their April FDA clearance for their flagship drug. They also have/had an FDA meeting this month regarding expanding the use of their drug for other diseases. Stock price been kinda beaten down since first approval announcement and it's pretty heavily shorted (~33% SI of last reporting). This could be for good reason but I don't know shit and like the company because of what they're trying to do. Anyways, if Tuesday brings major news there could be a good opportunity on Monday with 6/14 $7c and $8c being relatively cheap lotto tickets for any potential moves off the AGM (Friday close SP of $6.10). I'm holding shares but might grab a few of these on Monday. Edit: they could also provide bad news just because fuck me, but I'm betting on the positive."

Mentions:#IBRX#DD#AGM

Good morning degens. Usually I just make shitty jokes at other people's expense but this time I'm actually posting some potentially relevant info. IBRX has popped up a few times on here, either someone else posting DD or me spamming the ticker like the most basic bagholder ever (not really but it sure feels like it). Anyway, they have an AGM scheduled on Tuesday with some speculation of positive news following their April FDA clearance for their flagship drug. They also have/had an FDA meeting this month regarding expanding the use of their drug for other diseases. Stock price been kinda beaten down since first approval announcement and it's pretty heavily shorted (~33% SI of last reporting). This could be for good reason but I don't know shit and like the company because of what they're trying to do. Anyways, if Tuesday brings major news there could be a good opportunity on Monday with 6/14 $7c and $8c being relatively cheap lotto tickets for any potential moves off the AGM (Friday close SP of $6.10). I'm holding shares but might grab a few of these on Monday.

Mentions:#IBRX#DD#AGM

Yeah I've made a lot of *shit* speculative plays that haven't worked out. Still have a couple like IBRX as lotto tickets, but fuck me at least it has grander plans than selling Funko pops.

Mentions:#IBRX

$IBRX where is that FDA announcement???

Mentions:#IBRX

IBRX your dead to me... POS!

Mentions:#IBRX

I feel the sane about IBRX.

Mentions:#IBRX

My GoFundMe address is registered under ticker "IBRX". Feel free to donate to the regarded. This isn't a scam. I promise.

Mentions:#IBRX

https://preview.redd.it/czy740uaqv4d1.jpeg?width=1284&format=pjpg&auto=webp&s=7d43b6e4f32c063a8d90c1b57aaad0af8c21d16a Buy these IBRX $8 calls , 2 contracts worth , you'll thank me next week (2 IBRX 06/14 8c)

Mentions:#IBRX

IBRX, thanks for asking. Now if you could please purchase at least 1 million shares at $7, I would be very grateful. Think of this as a GoFundMe for a new found friend. Cheers!

Mentions:#IBRX

How should we understand this? ---------------------------- LadRx (OTCQB:LADX), a drug developer focused on chemotherapeutics, and California-based biotech, ImmunityBio (NASDAQ:IBRX) have reached a mutual agreement to terminate a licensing deal for aldoxorubicin, an investigational therapy targeted at soft tissue sarcoma and other cancers. XOMA Corporation (NASDAQ:XOMA), which bought royalty and milestone rights related to aldoxorubicin following a multimillion-dollar deal in 2023, has also given the go-ahead to the decision, the companies said in a statement late Monday. As the deal ends, LadRx (OTCQB:LADX) regains control of aldoxorubicin, which has already demonstrated its potential in a Phase 2 trial against a rare type of cancer called advanced soft tissue sarcoma. Concurrently, XOMA (XOMA) and ImmunityBio (IBRX) unit NantCell have revised their 2023 royalty purchase agreement related to aldoxorubicin. The companies said that per the revised deal, XOMA would receive a low-single-digit royalty and a mid-single-digit percentage of any economics generated from a potential out-licensing agreement related to the drug. “Over the coming months, we will be reviewing the pre-clinical and clinical data for aldoxorubicin and plotting a path forward for its continued clinical development,” LadRx (OTCQB:LADX) CEO Stephen Snowdy remarked. ----------------------------

How should we understand this? ---------------------------- ImmunityBio, LadRx end licensing deal for cancer drug Jun. 04, 2024 7:06 AM ETLadRx Corporation (LADX) Stock, IBRX Stock, XOMA StockBy: Dulan Lokuwithana, SA News Editor Deal is broken. Bad not secure deal ADragan LadRx (OTCQB:LADX), a drug developer focused on chemotherapeutics, and California-based biotech, ImmunityBio (NASDAQ:IBRX) have reached a mutual agreement to terminate a licensing deal for aldoxorubicin, an investigational therapy targeted at soft tissue sarcoma and other cancers. XOMA Corporation (NASDAQ:XOMA), which bought royalty and milestone rights related to aldoxorubicin following a multimillion-dollar deal in 2023, has also given the go-ahead to the decision, the companies said in a statement late Monday. As the deal ends, LadRx (OTCQB:LADX) regains control of aldoxorubicin, which has already demonstrated its potential in a Phase 2 trial against a rare type of cancer called advanced soft tissue sarcoma. Concurrently, XOMA (XOMA) and ImmunityBio (IBRX) unit NantCell have revised their 2023 royalty purchase agreement related to aldoxorubicin. The companies said that per the revised deal, XOMA would receive a low-single-digit royalty and a mid-single-digit percentage of any economics generated from a potential out-licensing agreement related to the drug. “Over the coming months, we will be reviewing the pre-clinical and clinical data for aldoxorubicin and plotting a path forward for its continued clinical development,” LadRx (OTCQB:LADX) CEO Stephen Snowdy remarked. ----------------------------

GME and IBRX (not just short play, long term as well)

Mentions:#GME#IBRX

Anyone have any fresh DD for IBRX? They have been speaking at the ASCO conference (ends Tuesday) and haven't heard a single peep/press release since it began on May 31...

Mentions:#DD#IBRX

In with 5k shares and 60 call options for end of next month. All about IBRX. Just need a catalyst. I expect them to report sales as well as a possible partnership on the 11th. Let's see!

Mentions:#IBRX

Don’t see it on the IBRX ir page. Link or tldr?

Mentions:#IBRX

Is my faith in IBRX going to be repaid after two green days in a row? Or will I continue to wallow in sadness that my favourite gamble is in the gutter? Find out at 4:30pm. No matter what, at least I can say I'm not a ber, even if it's to my ultimate financial despair.

Mentions:#IBRX

While I normally don’t waste time arguing with people on Reddit, I feel that I have to comment this time because you think you’re speaking the truth but in reality you’re wrong. First, let me say that I agree; definitely don’t buy any stocks you’re not comfortable with. We’re all strangers to each other here. But we do our best to be at least correct, yeah? Now let’s look at your list. Your claim is that “almost every” pharma stock goes down after FDA approval. And then you provide a list of companies. Within that list, IOVA went from $9 to $13 after approval and IBRX went from $4.9 to $8+ after approval. Furthermore, today’s event was not an FDA approval. It was a fact: Keytruda is inferior to Ivonescimab. Comparing apples to bananas. Keep your facts straight. You can choose not to believe me or buy in, but don’t be wrong about what you say

Mentions:#IOVA#IBRX

Similarity in terms of volume and price action: long grind down due to short selling pressure but instant moon once short thesis is disproved. In a way, IBRX commercial future is even more certain compared ASTS prior to AT&T and Verizon deals. IBRX Anktiva is already approved and sold at 30k+ per dose with capacity to manufacture 170k doses. The only thing missing is we don’t know how fast they are selling these and whether insurance are going to cover which has implications on short term prospect. Long term, it’s going to go up regardless.

Mentions:#IBRX#ASTS

Similar volume and/or short interest does not make ASTS and IBRX remotely similar what are you talking about? lol ASTS is in the tech industry with reported deals with Verizon and AT&T as you said. IBRX is a bio stock that’s still in clinical stage… what deals, partnerships, etc are you aware of that would cause the same kind of price movement?

Mentions:#ASTS#IBRX

agreed. i posted a dd in r/stocks a few days ago on IBRX. a winner both short and long term IMO

Mentions:#IBRX

I don’t understand why anyone would short IBRX. I’m holding bags for long term gains, they’re already commercializing an amazing product and just getting started. 🚀 🌕

Mentions:#IBRX

IBRX is literally a 4B market cap (similar to SPWR with $500m+ market cap) so not likely retail can do anything even with the short interest. On the other hand, SMFL has a 91.6%+ short interest and a 400k market cap.

Between BDRX and IBRX, I’m down bad, but IBRX is a long term play for me so I’m not stressed too hard about it

Mentions:#BDRX#IBRX

Calls - NVDA, CRWD, AMZN, VRT Shares - MU, SOUN, IBRX, PLTR

Not to mention IBRX

Mentions:#IBRX

Now is the time to get into IBRX @ $6.30

Mentions:#IBRX

The real key is having some kind of catalyst. Short % isn’t enough on its own but if the stock suddenly has something of value happen then that’s the combo that gets us places. Recent examples from this sub: RILY when the late 10-k was filed and IBRX when it got FDA approval for its cancer drug. Even if a stock has a low short % the rapid gains from a catalyst could force those shorts to close out but honestly what we’re doing here is looking for heavily undervalued stocks (which we found because their short % brought it to our attention) and hoping something that drives value in them happens.

Mentions:#RILY#IBRX

!banbet IBRX $9.00 10d

Mentions:#IBRX

I’m very very bullish on IBRX.

Mentions:#IBRX

Gonna keep loading up on more IBRX until mid June

Mentions:#IBRX

Could pop on Tuesday. Wells Fargo analysts just named IBRX as one of the mid cap biotechnology businesses to be acquired in a year.

Mentions:#IBRX

Nah, no scams here. Just all about IBRX.

Mentions:#IBRX

100% IBRX for the next 2-3 years. Just under 1500 shares. This stock is going to be 10 bagger I’m sure of it. ETFs are the way forward I’m just a twat.

Mentions:#IBRX

I have $3k worth of calls that will expire worthless in two weeks.... I got caught up in the excitement of what IBRX could offer and was especially delusional that perhaps a bigger pharma might express interest in buying them after FDA approval... That's what I get for letting my emotions get in the way of financial sense (especially when it comes to calls)! I should have sold when those calls were up 50%!

Mentions:#IBRX

Commenting so I can save this. I love IBRX.

Mentions:#IBRX

This is correct! I’m not super interested in investing in the company long term despite their good drug trial news (IBRX is my long term bio investment), but I haven’t sold any of my shares because BDRX is still the stock that is most primed for a short squeeze. It literally just needs volume.

Mentions:#IBRX#BDRX

What you aren’t mentioning is their massive debt load. I have been in IBRX since it was ~$1.00. Since then they have taken several large loans against their products. Their latest. Approval went almost unnoticed and little market reaction. Stack that with the market dilution of adding ~ 45% more stocks… the company effectively soaked up most of the predicted profit margins on stock values. While I agree it is a long term hold, that long term needs to be quantified. I see it as ~ 2 yrs, maybe longer.

Mentions:#IBRX

Does no one here know how long clinical trials take??? [https://www.reddit.com/r/investing/comments/n13d9f/basic\_overview\_of\_the\_fda\_drug\_approval\_process/](https://www.reddit.com/r/investing/comments/n13d9f/basic_overview_of_the_fda_drug_approval_process/) This is what you're dealing with. Now overlay the above with IBRX timeline/status. YEARS away unless interim news releases pump. [https://immunitybio.com/pipeline/](https://immunitybio.com/pipeline/) Are you SURE lung cancer is going for a fast track FDA? Please provide a source.

Mentions:#IBRX#SURE

Does no one here know how long clinical trials take??? [https://www.reddit.com/r/investing/comments/n13d9f/basic\_overview\_of\_the\_fda\_drug\_approval\_process/](https://www.reddit.com/r/investing/comments/n13d9f/basic_overview_of_the_fda_drug_approval_process/) This is what you're dealing with. Now overlay the above with IBRX timeline/status. YEARS away unless interim news releases pump. [https://immunitybio.com/pipeline/](https://immunitybio.com/pipeline/)

Mentions:#IBRX

All this and yet no one seems to want this stock and enthusiasm has faded. IBRX is being pumped hard a lot of people saying they went all in. Doesn’t make sense to me. I have 10 2025 calls at 10$ strike and will hold but not expecting much.

Mentions:#IBRX

Your sales estimates are way too optimistic - IBRX's lead drug is essentially a natural molecule and therefore unprotectable. Their sales are going to get cut into hard by biosimilars almost immediately.

Mentions:#IBRX

What happened to IBRX? Didn’t they cure cancer?!

Mentions:#IBRX

$IBRX

Mentions:#IBRX
r/stocksSee Comment

IBRX is not your typical bio-tech stock where the risk increases after fda approval. A lot of bio-tech stocks actually drop after fda approval because of potential logistics issues, are they able to meet production demands, supply chain and delivery issues, increased dilution to meet cash needs for ramp up. This is not IBRX. Dr Pat knows what he is doing as he already created and ramped up other biotech drug stocks in the last and sold them for multiple times the market cap. IBRX was already well positioned for the fda approval, has the agreement with serum institute of India in hand and had already purchased major manufacturing studios for production. Already had 20,000 doses produced and ready to ship and sent out 1,000 doses even before they were scheduled. This company, simply put, is not your typical biotech stock that could go to zero, they have a competent CEO that knows what he’s doing and has the playbook for a successful ramp up. I’m buying big.

Mentions:#IBRX
r/stocksSee Comment

Another trend that I’m noticing: the next decade will be the decade of immunotherapy. The FDA recently also approved an immunotherapy drug for small cell lung cancer: https://www.biopharmadive.com/news/amgen-imdelltra-fda-approval-tarlatamab-lung-cancer/716450/#:~:text=A%20bispecific%20antibody%2C%20Imdelltra%20is,stage%20small%20cell%20lung%20cancer. They are really digging immunotherapy and it’s a no brainer. Much better efficacy and significantly less side effect than chemo. Amgen drug is estimated to reach $842 million in 2028. Amgen current market cap is $155B, so 30x IBRX. Now here is the kicker: Amgen drug treats small cell lung cancer which is only 15% of lung cancer. The other 85% is non small lung cancer. Guess which type of lung cancer they are registering Anktiva for? https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-announces-positive-overall-survival-results-anktiva?field_nir_news_date_value%5Bmin%5D= That’s right - it’s non small lung cancer (you got this wrong in your DD), so 8x TAM of amgen drug. Then if Amgen is expected to sell 800M of SCLC drug, IBRX is looking at 6.4B in sales, excluding the billions from bladder cancer. Lastly, no dilution coming soon. i'd sell my house to buy this stock if I could

Mentions:#IBRX#DD

$IBRX is a long term play. If you're around $8 which I know alot are, just hold. I bought at $4 and caught the right swing. They have a lot of news coming out this summer and they do still have a high short float. With it trading and steadying out around $6.80/$7 its a buy imo. I truly see this thing holding around $10.50/$11 after the news this summer (assuming/hoping they continue the positive news).

Mentions:#IBRX

Downvote if need be, I understand that this whole thing is about taking calculated risks, but the most recent stocks I’ve seen from this sub have done nothing but lost money, FFIE, IBRX, BDRX, OKLO, RILY have all done nothing but take chunks from my portfolio, admittedly it’s money I was completely fine gambling, but when is something going to come about that in my mind would be exactly what this sub is made for? Kind of a rant but also a cry for something to recoup my money back and to remove the bitter taste from my mouth. TIA

IBRX to the moon!!

Mentions:#IBRX

Well team, yesterday was my worst day ever. Before that Friday and Thursday. 90% because of my decision to go harder into GWAV each time it burned me. Overall, my portfolio is down 50% since starting. Despite that, I'm still stupid enough to think GWAV is a good investment. But now I have no cash for swing trades because it's all stuck. Let me know when the bagholder support meetings are! Current plan is to wait on GWAV, AGBA, IBRX to grow my portfolio back into existence- which I'm expecting will be weeks or months, but I'd rather wait that lose most of my money jumping ship for something else. Ironically, FFEI was the only thing I timed right, getting out at 2.65. ...but then i put it into gwav... Someone wake me up when gwav is back over ten cents...

Employee trading windows opened after earnings or just biotech regressing. This is why I hated all the "BUY CALLS" and pump bs. Biotech goes up when there's catalyst news. But in the waiting periods, which we are in as we await further FDA news of clinical trials which can take YEARS, it always eats shit. If you can't HODL biotech through the doldrums, don't do it. It's also risky AF and we are always in for a nauseating ride. Anktiva is far from a sure bet. This time last year, IBRX was touting hopes for its performance in pancreatic cancer. Now, all mention of pancreatic cancer trials or hopes has basically disappeared from their narrative. Anktiva has extreme promise for NMIBC and approval. Now we have to see it's performance in other types of cancers. Immunology holds wonders for oncology but most of these weapons can't be broad and not every breakthrough is the next Keytruda. However, for the sake of my shares and for anyone affected by cancer, I hope this drug performs and gains approvals in many categories.

Mentions:#HODL#IBRX

Alright assholes, I’m now long IBRX. What does this company do again? If it doesn’t have something to do with the genitourinary tract, I’m out.

Mentions:#IBRX

IBRX ImmunityBio

Mentions:#IBRX

I’m down a bit myself after selling when it went from around $4 to $7. Currently In with my profits at the moment but doesn’t hurt as much. TBH, didn’t know much about the company initially but knowing more now I couldn’t be happier with the future of the stock $IBRX.

Mentions:#IBRX

Man what’s happening to IBRX rn is criminal. Not worried long term at all though

Mentions:#IBRX

why IBRX being shorted? It's snail oil or what?![img](emote|t5_2th52|27421)

Mentions:#IBRX

Should have got into $IBRX

Mentions:#IBRX

Liking this and IBRX but just picked up some Mara as well

Mentions:#IBRX

I love and fucking hate IBRX. It will pump at some point but waiting on it has meant I've missed out on other opportunities. I let it go at break even and will continue to watch it for re-entry. It's my white whale and I really believe in it long term.

Mentions:#IBRX

is it me or the IBRX chart is looking like a bullish flag forming?

Mentions:#IBRX

IBRX and OKLO with the nosedive.

Mentions:#IBRX#OKLO

Wtf why is IBRX in straight free fall

Mentions:#IBRX

IBRX is killing me right now but I keep reminding myself it's a long term play

Mentions:#IBRX

IBRX, you can move up too. This downward shit is getting old

Mentions:#IBRX

$IBRX for sure.

Mentions:#IBRX

I’m currently carrying both IBRX and ASTS, I’ve played the ups and downs on ASTS for years. ASTS is a sure bet, but I feel it will lose some hype and drop again before making their final accent up. It could still be awhile. IBRX has very little debt, about 20 million iirc and 300 million in cash on hand. Manufacturing is already setup, agreements with some insurance companies already written. Their first sale has already been made last week. That will be on their 2nd Q earnings report, to the tune of $38mil. That report is a long ways out. So I expect so volatility in SP. But as a long hold I find it a very safe bet. And outside chances of future price spike catalysts from possible FDA approval for use on lung cancer and possible other cancers have been shown to have prospective other uses as well. So possible other FDA approvals. Could make good short and long returns here too

Mentions:#IBRX#ASTS

$RILY, growing healthy reducing debts paying dividends consistently. $IBRX cancer treatment for bladder cancer has already been approved by the FDA and are seeing positive results for lung cancer treatment. $ASTS massive contract with AT&T to use satellites to eliminate cell towers, and have plans to expand to the rest of the world. 🤷‍♂️ more of long term plays with potential for a short squeeze. Con of $IBRX is their financials definitely need some work!

Hoping IBRX earnings happens tomorrow with good guidance.

Mentions:#IBRX

So the thing that makes $RILY good is that their company has goals that are achievable and are growing the company and have a plan for the next few quarters, it ain’t even a good short squeeze it’s just a good stock with good potential that could also be squeezed. Same with $IBRX really awesome cancer treatment company that just got FDA approved and $ASTS basically there will never be anywhere in the world without cell service because of their satellites they have just signed a contract with AT&T!

Also into $IBRX. After it was advertised here I've done a lot of DD and I'm absolutely pumped for this stock. If it doesn't squeeze, it is at least a very solid long term value play.

Mentions:#IBRX#DD

BS has a place in conspiracy theories ;) Appreciate the tip about $SLS and $IBRX - I’ll need to get up-to-speed in their science. But have been watching $IBRX climb lately.

Mentions:#SLS#IBRX

Same IBRX here. Tired of short term plays, need a break for a bit to just enjoy life without trading every week, so IBRX and index funds for long Not that I’m in the red or doing poorly, the opposite really. I’m up 40% for the year but it takes a lot of time and research on top of my regular job so just gonna go long for a while

Mentions:#IBRX

Agreed. And IBRX.

Mentions:#IBRX

Fuck the squeeze bullshit. IBRX is a long hold for great profits

Mentions:#IBRX

IBRX but more for long term potential than a squeeze actually

Mentions:#IBRX